PERRIGO COMPANY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.94 USD | +2.14% |
|
+3.70% | -0.75% |
| Apr. 25 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
| Apr. 25 | Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,031 | 6,104 | 5,204 | 4,590 | 4,361 | 4,238 | - | - |
| Enterprise Value (EV) 1 | 10,046 | 9,028 | 6,859 | 8,096 | 7,683 | 7,421 | 7,243 | 7,027 |
| P/E ratio | 48.3 x | -37.6 x | -74.8 x | -32.8 x | -358 x | -83.8 x | 55.8 x | 24.3 x |
| Yield | 1.59% | 2.01% | 2.47% | 3.05% | 3.39% | 3.52% | 3.75% | 4.04% |
| Capitalization / Revenue | 1.45 x | 1.21 x | 1.26 x | 1.03 x | 0.94 x | 0.91 x | 0.87 x | 0.84 x |
| EV / Revenue | 2.08 x | 1.78 x | 1.66 x | 1.82 x | 1.65 x | 1.59 x | 1.49 x | 1.39 x |
| EV / EBITDA | 11.2 x | 10.2 x | 11.9 x | 14 x | 11.6 x | 10.4 x | 9.04 x | 8.53 x |
| EV / FCF | 40.2 x | 19.4 x | 1,715 x | 38.4 x | 25.3 x | 19.9 x | 15.4 x | 13.4 x |
| FCF Yield | 2.49% | 5.16% | 0.06% | 2.61% | 3.95% | 5.02% | 6.48% | 7.46% |
| Price to Book | 1.21 x | 1.05 x | 1.01 x | 0.95 x | 0.91 x | 0.87 x | 0.83 x | 0.79 x |
| Nbr of stocks (in thousands) | 136,110 | 136,491 | 133,774 | 134,640 | 135,506 | 135,516 | - | - |
| Reference price 2 | 51.66 | 44.72 | 38.90 | 34.09 | 32.18 | 31.27 | 31.27 | 31.27 |
| Announcement Date | 2/27/20 | 3/1/21 | 3/1/22 | 2/27/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,837 | 5,063 | 4,139 | 4,452 | 4,656 | 4,658 | 4,862 | 5,040 |
| EBITDA 1 | 894.4 | 885.6 | 578 | 576.9 | 663.9 | 715.5 | 801 | 823.9 |
| EBIT 1 | 809.2 | 795.8 | 479 | 492.3 | 574.3 | 605.1 | 705.9 | 769.2 |
| Operating Margin | 16.73% | 15.72% | 11.57% | 11.06% | 12.34% | 12.99% | 14.52% | 15.26% |
| Earnings before Tax (EBT) 1 | 171 | - | - | -139.1 | -8.3 | -52.83 | 144 | 259.6 |
| Net income 1 | 146.1 | -162.6 | -68.9 | -140.6 | -12.7 | -51.25 | 100.8 | 197.8 |
| Net margin | 3.02% | -3.21% | -1.66% | -3.16% | -0.27% | -1.1% | 2.07% | 3.93% |
| EPS 2 | 1.070 | -1.190 | -0.5200 | -1.040 | -0.0900 | -0.3733 | 0.5600 | 1.285 |
| Free Cash Flow 1 | 250.1 | 465.8 | 4 | 210.9 | 303.8 | 372.7 | 469.7 | 524.3 |
| FCF margin | 5.17% | 9.2% | 0.1% | 4.74% | 6.53% | 8% | 9.66% | 10.4% |
| FCF Conversion (EBITDA) | 27.96% | 52.6% | 0.69% | 36.56% | 45.76% | 52.09% | 58.64% | 63.64% |
| FCF Conversion (Net income) | 171.18% | - | - | - | - | - | 465.82% | 265.04% |
| Dividend per Share 2 | 0.8200 | 0.9000 | 0.9600 | 1.040 | 1.090 | 1.102 | 1.172 | 1.263 |
| Announcement Date | 2/27/20 | 3/1/21 | 3/1/22 | 2/27/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,043 | 1,105 | 1,074 | 1,122 | 1,100 | 1,155 | 1,182 | 1,193 | 1,124 | 1,157 | 1,107 | 1,180 | 1,159 | 1,208 | 1,156 |
| EBITDA 1 | 132.7 | 153.3 | 107.4 | 136.7 | 153.3 | 178.7 | 142.7 | 161.5 | 173 | 186.6 | 108.5 | 152 | 195 | 210.1 | 191.9 |
| EBIT 1 | 111.6 | 131.5 | 86.8 | 116.4 | 133 | 156 | 119.6 | 137.3 | 150.3 | 167.1 | 88.63 | 136.8 | 177.7 | 202.1 | 169.4 |
| Operating Margin | 10.7% | 11.9% | 8.08% | 10.38% | 12.09% | 13.5% | 10.12% | 11.51% | 13.37% | 14.44% | 8.01% | 11.6% | 15.32% | 16.73% | 14.66% |
| Earnings before Tax (EBT) 1 | - | - | - | - | -3.5 | -14.3 | 4.3 | - | - | -54.4 | -62.6 | -31.45 | 6.75 | 34.55 | 51.2 |
| Net income 1 | - | - | - | - | -49.4 | -23.7 | - | 8.4 | - | -32.3 | -45 | -27.45 | 3.05 | 13.37 | 36.1 |
| Net margin | - | - | - | - | -4.49% | -2.05% | - | 0.7% | - | -2.79% | -4.07% | -2.33% | 0.26% | 1.11% | 3.12% |
| EPS 2 | -0.4400 | - | - | - | -0.3700 | -0.1700 | -0.0200 | 0.0600 | - | -0.2400 | -0.2300 | - | 0.2900 | -0.0700 | - |
| Dividend per Share 2 | 0.2400 | 0.2400 | 0.2600 | 0.2600 | 0.2600 | 0.2600 | 0.2700 | 0.2700 | 0.2700 | 0.2800 | 0.2800 | 0.2800 | 0.2800 | 0.2800 | - |
| Announcement Date | 11/10/21 | 3/1/22 | 5/11/22 | 8/9/22 | 11/8/22 | 2/27/23 | 5/9/23 | 8/8/23 | 11/7/23 | 2/27/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 3,015 | 2,925 | 1,656 | 3,506 | 3,322 | 3,183 | 3,006 | 2,789 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.371 x | 3.302 x | 2.864 x | 6.077 x | 5.004 x | 4.449 x | 3.753 x | 3.386 x |
| Free Cash Flow 1 | 250 | 466 | 4 | 211 | 304 | 373 | 470 | 524 |
| ROE (net income / shareholders' equity) | 9.58% | 9.74% | 5.14% | 5.62% | 7.33% | 7.17% | 8.55% | 9% |
| ROA (Net income/ Total Assets) | 1.31% | -1.43% | 2.53% | 2.62% | 3.23% | 3.25% | 4.05% | 4.41% |
| Assets 1 | 11,142 | 11,395 | -2,720 | -5,366 | -393.7 | -1,579 | 2,492 | 4,490 |
| Book Value Per Share 2 | 42.60 | 42.50 | 38.50 | 35.90 | 35.20 | 36.00 | 37.60 | 39.50 |
| Cash Flow per Share 2 | 2.840 | - | - | - | 3.000 | 3.910 | 4.120 | 4.760 |
| Capex 1 | 138 | 170 | 152 | 96.4 | 102 | 123 | 125 | 125 |
| Capex / Sales | 2.85% | 3.37% | 3.68% | 2.17% | 2.18% | 2.64% | 2.57% | 2.48% |
| Announcement Date | 2/27/20 | 3/1/21 | 3/1/22 | 2/27/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
31.94
USD
Average target price
39.72
USD
Spread / Average Target
+24.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.75% | 4.24B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
- Stock Market
- Equities
- PRGO Stock
- Financials Perrigo Company plc
